肝肾综合征 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "肝肾综合征" in Chinese language version.

refsWebsite

Global rank Chinese rank

83nih.gov

4^th place

5^th place

47worldcat.org

5^th place

12^th place

45web.archive.org

1^st place

45doi.org

2^nd place

23^rd place

5nejm.org

2,374^th place

1,457^th place

3asnjournals.org

low place

2elsevier.com

610^th place

388^th place

1medscape.com

719^th place

889^th place

1lww.com

2,769^th place

1,362^nd place

1wjgnet.com

low place

6,583^rd place

1uptodate.com

3,771^st place

4,225^th place

1hindawi.com

6,828^th place

3,089^th place

1mendeley.com

low place

asnjournals.org (Global: low place; Chinese: low place)

cjasn.asnjournals.org

Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.

jasn.asnjournals.org

Ginès, Pere; Arroyo, Vicente. Hepatorenal Syndrome. Journal of the American Society of Nephrology. 1999-08-01, 10 (8): 1833–1839 [2021-03-01]. ISSN 1046-6673. PMID 10446954. （原始内容存档于2021-05-06）（英语）.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Arroyo, V.; Ginès, P.; Gerbes, A. L.; Dudley, F. J.; Gentilini, P.; Laffi, G.; Reynolds, T. B.; Ring-Larsen, H.; Schölmerich, J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (Baltimore, Md.). 1996-01, 23 (1): 164–176 [2021-03-01]. ISSN 0270-9139. PMID 8550036. doi:10.1002/hep.510230122. （原始内容存档于2021-05-06）.
Arroyo, Vicente; Guevara, Mónica; Ginès, Pere. Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment. Gastroenterology. 2002-05, 122 (6): 1658–1676 [2020-09-17]. PMID 12016430. doi:10.1053/gast.2002.33575. （原始内容存档于2019-06-06）（英语）.
Lenz, Kurt; Buder, Robert; Kapun, Lisbeth; Voglmayr, Martin. Treatment and management of ascites and hepatorenal syndrome: an update. Therapeutic Advances in Gastroenterology. 2015-03, 8 (2): 83–100 [2019-01-09]. ISSN 1756-283X. PMC 4314304 . PMID 25729433. doi:10.1177/1756283X14564673. （原始内容存档于2021-05-06）.
Ginés, P.; Arroyo, V.; Quintero, E.; Planas, R.; Bory, F.; Cabrera, J.; Rimola, A.; Viver, J.; Camps, J. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987-08, 93 (2): 234–241 [2021-03-01]. ISSN 0016-5085. PMID 3297907. doi:10.1016/0016-5085(87)91007-9. （原始内容存档于2021-05-06）.
Blendis, Laurie; Wong, Florence. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clinical Medicine (London, England). 2003-03, 3 (2): 154–159 [2021-03-01]. ISSN 1470-2118. PMC 4952737 . PMID 12737373. doi:10.7861/clinmedicine.3-2-154. （原始内容存档于2021-05-06）.
Ginès, A.; Escorsell, A.; Ginès, P.; Saló, J.; Jiménez, W.; Inglada, L.; Navasa, M.; Clària, J.; Rimola, A. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993-07, 105 (1): 229–236 [2021-03-01]. ISSN 0016-5085. PMID 8514039. doi:10.1016/0016-5085(93)90031-7. （原始内容存档于2021-05-06）.
Han, Steven-Huy B. Extrahepatic manifestations of chronic hepatitis B. Clinics in Liver Disease. 2004-05, 8 (2): 403–418 [2021-03-01]. ISSN 1089-3261. PMID 15481347. doi:10.1016/j.cld.2004.02.003. （原始内容存档于2021-05-06）.
Philipneri, M.; Bastani, B. Kidney disease in patients with chronic hepatitis C. Current Gastroenterology Reports. 2001-02, 3 (1): 79–83 [2021-03-01]. ISSN 1522-8037. PMID 11177699. doi:10.1007/s11894-001-0045-0. （原始内容存档于2021-05-06）.
Schrier, R. W.; Arroyo, V.; Bernardi, M.; Epstein, M.; Henriksen, J. H.; Rodés, J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (Baltimore, Md.). 1988-09, 8 (5): 1151–1157 [2021-03-01]. ISSN 0270-9139. PMID 2971015. doi:10.1002/hep.1840080532. （原始内容存档于2021-05-06）.
Martin, Pierre-Yves; Ginès, Pere; Schrier, Robert W. Epstein, Franklin H. , 编. Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis. New England Journal of Medicine. 1998-08-20, 339 (8): 533–541 [2021-03-01]. ISSN 0028-4793. PMID 9709047. doi:10.1056/NEJM199808203390807. （原始内容存档于2021-05-06）（英语）.
Fernandez-Seara, J.; Prieto, J.; Quiroga, J.; Zozaya, J. M.; Cobos, M. A.; Rodriguez-Eire, J. L.; Garcia-Plaza, A.; Leal, J. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989-11, 97 (5): 1304–1312 [2021-03-01]. ISSN 0016-5085. PMID 2676683. doi:10.1016/0016-5085(89)91704-6. （原始内容存档于2021-05-06）.
Lenz, K.; Hörtnagl, H.; Druml, W.; Reither, H.; Schmid, R.; Schneeweiss, B.; Laggner, A.; Grimm, G.; Gerbes, A. L. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991-10, 101 (4): 1060–1067 [2021-03-01]. ISSN 0016-5085. PMID 1832407. doi:10.1016/0016-5085(91)90734-3. （原始内容存档于2021-05-06）.
Moore, K.; Ward, P. S.; Taylor, G. W.; Williams, R. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 1991-04, 100 (4): 1069–1077 [2021-03-01]. ISSN 0016-5085. PMID 2001805. doi:10.1016/0016-5085(91)90284-r. （原始内容存档于2021-05-06）.
Kaffy, F.; Borderie, C.; Chagneau, C.; Ripault, M. P.; Larzillière, I.; Silvain, C.; Beauchant, M. Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients. Journal of Hepatology. 1999-01, 30 (1): 174 [2021-03-01]. ISSN 0168-8278. PMID 9927168. doi:10.1016/s0168-8278(99)80025-7. （原始内容存档于2021-05-06）.
Schroeder, E. T.; Anderson, G. H.; Smulyan, H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney International. 1979-01, 15 (1): 54–61 [2021-03-01]. ISSN 0085-2538. PMID 491398. doi:10.1038/ki.1979.8. （原始内容存档于2021-05-06）.
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology. 2010-09, 53 (3): 397–417 [2021-03-01]. doi:10.1016/j.jhep.2010.05.004. （原始内容存档于2021-05-06）（英语）.
Velamati, Praveena G.; Herlong, H. Franklin. Treatment of refractory ascites. Current Treatment Options in Gastroenterology. 2006, 9 (6): 530–537 [2021-03-01]. ISSN 1092-8472. PMID 17081486. doi:10.1007/s11938-006-0009-4. （原始内容存档于2021-05-06）.
Sort, Pau; Navasa, Miquel; Arroyo, Vicente; Aldeguer, Xavier; Planas, Ramon; Ruiz-del-Arbol, Luis; Castells, Lluis; Vargas, Victor; Soriano, Germán. Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. New England Journal of Medicine. 1999-08-05, 341 (6): 403–409. ISSN 0028-4793. PMID 10432325. doi:10.1056/NEJM199908053410603 （英语）.
Wong, F.; Blendis, L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology (Baltimore, Md.). 2001-12, 34 (6): 1242–1251 [2021-03-01]. ISSN 0270-9139. PMID 11732014. doi:10.1053/jhep.2001.29200. （原始内容存档于2021-05-06）.
Xu, Xiao; Ling, Qi; Zhang, Min; Gao, Feng; He, Zenglei; You, Jingya; Zheng, Shusen. Outcome of Patients With Hepatorenal Syndrome Type 1 After Liver Transplantation: Hangzhou Experience. Transplantation. 2009-05-27, 87 (10): 1514–1519. ISSN 0041-1337. PMID 19461488. doi:10.1097/TP.0b013e3181a4430b （英语）.
Guevara, M.; Ginès, P.; Fernández-Esparrach, G.; Sort, P.; Salmerón, J. M.; Jiménez, W.; Arroyo, V.; Rodés, J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology (Baltimore, Md.). 1998-01, 27 (1): 35–41 [2021-03-01]. ISSN 0270-9139. PMID 9425914. doi:10.1002/hep.510270107. （原始内容存档于2021-05-06）.
Ortega, Rolando; Ginès, Pere; Uriz, Juan; Cárdenas, Andrés; Calahorra, Blas; De Las Heras, Dara; Guevara, Mónica; Bataller, Ramón; Jiménez, Wladimiro. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology (Baltimore, Md.). 2002-10, 36 (4 Pt 1): 941–948 [2021-03-01]. ISSN 0270-9139. PMID 12297842. doi:10.1053/jhep.2002.35819. （原始内容存档于2021-05-06）.
Ginès, Pere; Cárdenas, Andrés; Arroyo, Vicente; Rodés, Juan. Management of Cirrhosis and Ascites. New England Journal of Medicine. 2004-04-15, 350 (16): 1646–1654. ISSN 0028-4793. PMID 15084697. doi:10.1056/NEJMra035021 （英语）.
Martín-Llahí, Marta; Pépin, Marie-Noëlle; Guevara, Mónica; Díaz, Fernando; Torre, Aldo; Monescillo, Alberto; Soriano, Germán; Terra, Carlos; Fábrega, Emilio. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008-05, 134 (5): 1352–1359 [2021-03-01]. ISSN 1528-0012. PMID 18471512. doi:10.1053/j.gastro.2008.02.024. （原始内容存档于2021-05-06）.
Pomier-Layrargues, Gilles; Paquin, Sarto C.; Hassoun, Ziad; Lafortune, Michel; Tran, Albert. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology (Baltimore, Md.). 2003-07, 38 (1): 238–243 [2021-03-01]. ISSN 0270-9139. PMID 12830007. doi:10.1053/jhep.2003.50276. （原始内容存档于2021-05-06）.
Angeli, P.; Volpin, R.; Gerunda, G.; Craighero, R.; Roner, P.; Merenda, R.; Amodio, P.; Sticca, A.; Caregaro, L. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (Baltimore, Md.). 1999-06, 29 (6): 1690–1697 [2021-03-01]. ISSN 0270-9139. PMID 10347109. doi:10.1002/hep.510290629. （原始内容存档于2021-05-06）.
Esrailian, Eric; Pantangco, Eugene R.; Kyulo, Namgyal L.; Hu, Ke-Qin; Runyon, Bruce A. Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Digestive Diseases and Sciences. 2007-03, 52 (3): 742–748 [2021-03-01]. ISSN 0163-2116. PMID 17235705. doi:10.1007/s10620-006-9312-0. （原始内容存档于2021-05-06）.
Gülberg, V.; Bilzer, M.; Gerbes, A. L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology (Baltimore, Md.). 1999-10, 30 (4): 870–875 [2021-03-01]. ISSN 0270-9139. PMID 10498636. doi:10.1002/hep.510300430. （原始内容存档于2021-05-06）.
Gluud, Lise Lotte; Christensen, Kurt; Christensen, Erik; Krag, Aleksander. Terlipressin for hepatorenal syndrome. The Cochrane Database of Systematic Reviews. 2012-09-12, (9): CD005162 [2021-03-01]. ISSN 1469-493X. PMID 22972083. doi:10.1002/14651858.CD005162.pub3. （原始内容存档于2021-05-06）.
Fernández, Javier; Navasa, Miquel; Planas, Ramón; Montoliu, Silvia; Monfort, David; Soriano, German; Vila, Carmen; Pardo, Alberto; Quintero, Enrique. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007-09, 133 (3): 818–824 [2021-03-01]. ISSN 0016-5085. PMID 17854593. doi:10.1053/j.gastro.2007.06.065. （原始内容存档于2021-05-06）.
Akriviadis, E.; Botla, R.; Briggs, W.; Han, S.; Reynolds, T.; Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000-12, 119 (6): 1637–1648 [2021-03-01]. ISSN 0016-5085. PMID 11113085. doi:10.1053/gast.2000.20189. （原始内容存档于2021-05-06）.
Holt, S.; Goodier, D.; Marley, R.; Patch, D.; Burroughs, A.; Fernando, B.; Harry, D.; Moore, K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (London, England). 1999-01-23, 353 (9149): 294–295 [2021-03-01]. ISSN 0140-6736. PMID 9929029. doi:10.1016/s0140-6736(05)74933-3. （原始内容存档于2021-05-06）.
Wong, Florence; Pantea, Lavinia; Sniderman, Kenneth. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (Baltimore, Md.). 2004-07, 40 (1): 55–64 [2021-03-01]. ISSN 0270-9139. PMID 15239086. doi:10.1002/hep.20262. （原始内容存档于2021-05-06）.
Guevara, Mónica; Rodés, Juan. Hepatorenal syndrome. The International Journal of Biochemistry & Cell Biology. 2005-01, 37 (1): 22–26 [2021-03-01]. ISSN 1357-2725. PMID 15381144. doi:10.1016/j.biocel.2004.06.007. （原始内容存档于2021-05-06）.
Mitzner, S. R.; Stange, J.; Klammt, S.; Risler, T.; Erley, C. M.; Bader, B. D.; Berger, E. D.; Lauchart, W.; Peszynski, P. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000-05, 6 (3): 277–286 [2021-03-01]. ISSN 1527-6465. PMID 10827226. doi:10.1002/lt.500060326. （原始内容存档于2021-05-06）.
Dundar, Halit Ziya. Management of hepatorenal syndrome. World Journal of Nephrology. 2015, 4 (2): 277 [2021-03-01]. ISSN 2220-6124. PMC 4419138 . PMID 25949942. doi:10.5527/wjn.v4.i2.277. （原始内容存档于2021-05-06）（英语）.
Wong, Leslie P.; Blackley, Molly P.; Andreoni, Kenneth A.; Chin, Hyunsook; Falk, Ronald J.; Klemmer, Philip J. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney International. 2005-07, 68 (1): 362–370 [2021-03-01]. ISSN 0085-2538. PMID 15954928. doi:10.1111/j.1523-1755.2005.00408.x. （原始内容存档于2021-05-06）.
Ginès, Pere; Schrier, Robert W. Renal Failure in Cirrhosis. New England Journal of Medicine. 2009-09-24, 361 (13): 1279–1290. ISSN 0028-4793. PMID 19776409. doi:10.1056/NEJMra0809139 （英语）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Alessandria, Carlo; Ozdogan, Osman; Guevara, Mónica; Restuccia, Tea; Jiménez, Wladimiro; Arroyo, Vicente; Rodés, Juan; Ginès, Pere. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (Baltimore, Md.). 2005-06, 41 (6): 1282–1289 [2021-03-01]. ISSN 0270-9139. PMID 15834937. doi:10.1002/hep.20687. （原始内容存档于2021-05-06）.
Low, G.; Alexander, G. J. M.; Lomas, D. J. Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterology Research and Practice. 2015, 2015: 1–11 [2017-11-25]. ISSN 1687-6121. PMC 4306364 . PMID 25649410. doi:10.1155/2015/207012. （原始内容存档于2021-05-06）（英语）.
Better, O. S. Renal and cardiovascular dysfunction in liver disease. Kidney International. 1986-02, 29 (2): 598–607 [2021-03-01]. ISSN 0085-2538. PMID 3702216. doi:10.1038/ki.1986.40. （原始内容存档于2021-05-06）.
Hecker, R.; Sherlock, S. Electrolyte and circulatory changes in terminal liver failure. Lancet (London, England). 1956-12-01, 271 (6953): 1121–1125 [2021-03-01]. ISSN 0140-6736. PMID 13377688. doi:10.1016/s0140-6736(56)90149-0. （原始内容存档于2021-05-06）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Koppel, Marcelo H.; Coburn, Jack W.; Mims, Matlock M.; Goldstein, Howard; Boyle, James D.; Rubini, Milton E. Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome: Evidence for the Functional Nature of Renal Failure in Advanced Liver Disease. New England Journal of Medicine. 1969-06-19, 280 (25): 1367–1371. ISSN 0028-4793. PMID 4890476. doi:10.1056/NEJM196906192802501 （英语）.

elsevier.com (Global: 610^th place; Chinese: 388^th place)

linkinghub.elsevier.com

Arroyo, Vicente; Guevara, Mónica; Ginès, Pere. Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment. Gastroenterology. 2002-05, 122 (6): 1658–1676 [2020-09-17]. PMID 12016430. doi:10.1053/gast.2002.33575. （原始内容存档于2019-06-06）（英语）.
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology. 2010-09, 53 (3): 397–417 [2021-03-01]. doi:10.1016/j.jhep.2010.05.004. （原始内容存档于2021-05-06）（英语）.

hindawi.com (Global: 6,828^th place; Chinese: 3,089^th place)

Low, G.; Alexander, G. J. M.; Lomas, D. J. Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterology Research and Practice. 2015, 2015: 1–11 [2017-11-25]. ISSN 1687-6121. PMC 4306364 . PMID 25649410. doi:10.1155/2015/207012. （原始内容存档于2021-05-06）（英语）.

lww.com (Global: 2,769^th place; Chinese: 1,362^nd place)

journals.lww.com

Xu, Xiao; Ling, Qi; Zhang, Min; Gao, Feng; He, Zenglei; You, Jingya; Zheng, Shusen. Outcome of Patients With Hepatorenal Syndrome Type 1 After Liver Transplantation: Hangzhou Experience. Transplantation. 2009-05-27, 87 (10): 1514–1519. ISSN 0041-1337. PMID 19461488. doi:10.1097/TP.0b013e3181a4430b （英语）.

medscape.com (Global: 719^th place; Chinese: 889^th place)

emedicine.medscape.com

Hepatorenal Syndrome: Background, Pathophysiology, Etiology. 2020-03-23 [2021-03-01]. （原始内容存档于2017-08-10）.

mendeley.com (Global: low place; Chinese: low place)

Helwig, F. C.; Schutz, C. B. A liver kidney syndrome. Clinical, pathological and experimental studies.. Surg Gynaecol Obstet. 1932, 55: 570–580 [2021-03-01]. （原始内容存档于2021-05-06）（英国英语）.

nejm.org (Global: 2,374^th place; Chinese: 1,457^th place)

Martin, Pierre-Yves; Ginès, Pere; Schrier, Robert W. Epstein, Franklin H. , 编. Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis. New England Journal of Medicine. 1998-08-20, 339 (8): 533–541 [2021-03-01]. ISSN 0028-4793. PMID 9709047. doi:10.1056/NEJM199808203390807. （原始内容存档于2021-05-06）（英语）.
Sort, Pau; Navasa, Miquel; Arroyo, Vicente; Aldeguer, Xavier; Planas, Ramon; Ruiz-del-Arbol, Luis; Castells, Lluis; Vargas, Victor; Soriano, Germán. Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. New England Journal of Medicine. 1999-08-05, 341 (6): 403–409. ISSN 0028-4793. PMID 10432325. doi:10.1056/NEJM199908053410603 （英语）.
Ginès, Pere; Cárdenas, Andrés; Arroyo, Vicente; Rodés, Juan. Management of Cirrhosis and Ascites. New England Journal of Medicine. 2004-04-15, 350 (16): 1646–1654. ISSN 0028-4793. PMID 15084697. doi:10.1056/NEJMra035021 （英语）.
Ginès, Pere; Schrier, Robert W. Renal Failure in Cirrhosis. New England Journal of Medicine. 2009-09-24, 361 (13): 1279–1290. ISSN 0028-4793. PMID 19776409. doi:10.1056/NEJMra0809139 （英语）.
Koppel, Marcelo H.; Coburn, Jack W.; Mims, Matlock M.; Goldstein, Howard; Boyle, James D.; Rubini, Milton E. Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome: Evidence for the Functional Nature of Renal Failure in Advanced Liver Disease. New England Journal of Medicine. 1969-06-19, 280 (25): 1367–1371. ISSN 0028-4793. PMID 4890476. doi:10.1056/NEJM196906192802501 （英语）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Ng, Charles K. F.; Chan, Michael H. M.; Tai, Morris H. L.; Lam, Christopher W. K. Hepatorenal syndrome. The Clinical Biochemist. Reviews. 2007-02, 28 (1): 11–17 [2021-03-01]. ISSN 0159-8090. PMC 1904420 . PMID 17603637. （原始内容存档于2021-05-06）.
Ginès, Pere; Arroyo, Vicente. Hepatorenal Syndrome. Journal of the American Society of Nephrology. 1999-08-01, 10 (8): 1833–1839 [2021-03-01]. ISSN 1046-6673. PMID 10446954. （原始内容存档于2021-05-06）（英语）.
Arroyo, V.; Ginès, P.; Gerbes, A. L.; Dudley, F. J.; Gentilini, P.; Laffi, G.; Reynolds, T. B.; Ring-Larsen, H.; Schölmerich, J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (Baltimore, Md.). 1996-01, 23 (1): 164–176 [2021-03-01]. ISSN 0270-9139. PMID 8550036. doi:10.1002/hep.510230122. （原始内容存档于2021-05-06）.
Arroyo, Vicente; Guevara, Mónica; Ginès, Pere. Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment. Gastroenterology. 2002-05, 122 (6): 1658–1676 [2020-09-17]. PMID 12016430. doi:10.1053/gast.2002.33575. （原始内容存档于2019-06-06）（英语）.
Lenz, Kurt; Buder, Robert; Kapun, Lisbeth; Voglmayr, Martin. Treatment and management of ascites and hepatorenal syndrome: an update. Therapeutic Advances in Gastroenterology. 2015-03, 8 (2): 83–100 [2019-01-09]. ISSN 1756-283X. PMC 4314304 . PMID 25729433. doi:10.1177/1756283X14564673. （原始内容存档于2021-05-06）.
Ginés, P.; Arroyo, V.; Quintero, E.; Planas, R.; Bory, F.; Cabrera, J.; Rimola, A.; Viver, J.; Camps, J. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987-08, 93 (2): 234–241 [2021-03-01]. ISSN 0016-5085. PMID 3297907. doi:10.1016/0016-5085(87)91007-9. （原始内容存档于2021-05-06）.
Blendis, Laurie; Wong, Florence. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clinical Medicine (London, England). 2003-03, 3 (2): 154–159 [2021-03-01]. ISSN 1470-2118. PMC 4952737 . PMID 12737373. doi:10.7861/clinmedicine.3-2-154. （原始内容存档于2021-05-06）.
Ginès, A.; Escorsell, A.; Ginès, P.; Saló, J.; Jiménez, W.; Inglada, L.; Navasa, M.; Clària, J.; Rimola, A. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993-07, 105 (1): 229–236 [2021-03-01]. ISSN 0016-5085. PMID 8514039. doi:10.1016/0016-5085(93)90031-7. （原始内容存档于2021-05-06）.
Han, Steven-Huy B. Extrahepatic manifestations of chronic hepatitis B. Clinics in Liver Disease. 2004-05, 8 (2): 403–418 [2021-03-01]. ISSN 1089-3261. PMID 15481347. doi:10.1016/j.cld.2004.02.003. （原始内容存档于2021-05-06）.
Philipneri, M.; Bastani, B. Kidney disease in patients with chronic hepatitis C. Current Gastroenterology Reports. 2001-02, 3 (1): 79–83 [2021-03-01]. ISSN 1522-8037. PMID 11177699. doi:10.1007/s11894-001-0045-0. （原始内容存档于2021-05-06）.
Schrier, R. W.; Arroyo, V.; Bernardi, M.; Epstein, M.; Henriksen, J. H.; Rodés, J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (Baltimore, Md.). 1988-09, 8 (5): 1151–1157 [2021-03-01]. ISSN 0270-9139. PMID 2971015. doi:10.1002/hep.1840080532. （原始内容存档于2021-05-06）.
Martin, Pierre-Yves; Ginès, Pere; Schrier, Robert W. Epstein, Franklin H. , 编. Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis. New England Journal of Medicine. 1998-08-20, 339 (8): 533–541 [2021-03-01]. ISSN 0028-4793. PMID 9709047. doi:10.1056/NEJM199808203390807. （原始内容存档于2021-05-06）（英语）.
Epstein, M. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. Journal of the American Society of Nephrology: JASN. 1994-04, 4 (10): 1735–1753 [2021-03-01]. ISSN 1046-6673. PMID 8068872. （原始内容存档于2021-05-06）.
Fernandez-Seara, J.; Prieto, J.; Quiroga, J.; Zozaya, J. M.; Cobos, M. A.; Rodriguez-Eire, J. L.; Garcia-Plaza, A.; Leal, J. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989-11, 97 (5): 1304–1312 [2021-03-01]. ISSN 0016-5085. PMID 2676683. doi:10.1016/0016-5085(89)91704-6. （原始内容存档于2021-05-06）.
Lenz, K.; Hörtnagl, H.; Druml, W.; Reither, H.; Schmid, R.; Schneeweiss, B.; Laggner, A.; Grimm, G.; Gerbes, A. L. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991-10, 101 (4): 1060–1067 [2021-03-01]. ISSN 0016-5085. PMID 1832407. doi:10.1016/0016-5085(91)90734-3. （原始内容存档于2021-05-06）.
Moore, K.; Ward, P. S.; Taylor, G. W.; Williams, R. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 1991-04, 100 (4): 1069–1077 [2021-03-01]. ISSN 0016-5085. PMID 2001805. doi:10.1016/0016-5085(91)90284-r. （原始内容存档于2021-05-06）.
Kaffy, F.; Borderie, C.; Chagneau, C.; Ripault, M. P.; Larzillière, I.; Silvain, C.; Beauchant, M. Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients. Journal of Hepatology. 1999-01, 30 (1): 174 [2021-03-01]. ISSN 0168-8278. PMID 9927168. doi:10.1016/s0168-8278(99)80025-7. （原始内容存档于2021-05-06）.
Schroeder, E. T.; Anderson, G. H.; Smulyan, H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney International. 1979-01, 15 (1): 54–61 [2021-03-01]. ISSN 0085-2538. PMID 491398. doi:10.1038/ki.1979.8. （原始内容存档于2021-05-06）.
Velamati, Praveena G.; Herlong, H. Franklin. Treatment of refractory ascites. Current Treatment Options in Gastroenterology. 2006, 9 (6): 530–537 [2021-03-01]. ISSN 1092-8472. PMID 17081486. doi:10.1007/s11938-006-0009-4. （原始内容存档于2021-05-06）.
Sort, Pau; Navasa, Miquel; Arroyo, Vicente; Aldeguer, Xavier; Planas, Ramon; Ruiz-del-Arbol, Luis; Castells, Lluis; Vargas, Victor; Soriano, Germán. Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. New England Journal of Medicine. 1999-08-05, 341 (6): 403–409. ISSN 0028-4793. PMID 10432325. doi:10.1056/NEJM199908053410603 （英语）.
Wong, F.; Blendis, L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology (Baltimore, Md.). 2001-12, 34 (6): 1242–1251 [2021-03-01]. ISSN 0270-9139. PMID 11732014. doi:10.1053/jhep.2001.29200. （原始内容存档于2021-05-06）.
Xu, Xiao; Ling, Qi; Zhang, Min; Gao, Feng; He, Zenglei; You, Jingya; Zheng, Shusen. Outcome of Patients With Hepatorenal Syndrome Type 1 After Liver Transplantation: Hangzhou Experience. Transplantation. 2009-05-27, 87 (10): 1514–1519. ISSN 0041-1337. PMID 19461488. doi:10.1097/TP.0b013e3181a4430b （英语）.
Guevara, M.; Ginès, P.; Fernández-Esparrach, G.; Sort, P.; Salmerón, J. M.; Jiménez, W.; Arroyo, V.; Rodés, J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology (Baltimore, Md.). 1998-01, 27 (1): 35–41 [2021-03-01]. ISSN 0270-9139. PMID 9425914. doi:10.1002/hep.510270107. （原始内容存档于2021-05-06）.
Ortega, Rolando; Ginès, Pere; Uriz, Juan; Cárdenas, Andrés; Calahorra, Blas; De Las Heras, Dara; Guevara, Mónica; Bataller, Ramón; Jiménez, Wladimiro. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology (Baltimore, Md.). 2002-10, 36 (4 Pt 1): 941–948 [2021-03-01]. ISSN 0270-9139. PMID 12297842. doi:10.1053/jhep.2002.35819. （原始内容存档于2021-05-06）.
Ginès, Pere; Cárdenas, Andrés; Arroyo, Vicente; Rodés, Juan. Management of Cirrhosis and Ascites. New England Journal of Medicine. 2004-04-15, 350 (16): 1646–1654. ISSN 0028-4793. PMID 15084697. doi:10.1056/NEJMra035021 （英语）.
Martín-Llahí, Marta; Pépin, Marie-Noëlle; Guevara, Mónica; Díaz, Fernando; Torre, Aldo; Monescillo, Alberto; Soriano, Germán; Terra, Carlos; Fábrega, Emilio. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008-05, 134 (5): 1352–1359 [2021-03-01]. ISSN 1528-0012. PMID 18471512. doi:10.1053/j.gastro.2008.02.024. （原始内容存档于2021-05-06）.
Pomier-Layrargues, Gilles; Paquin, Sarto C.; Hassoun, Ziad; Lafortune, Michel; Tran, Albert. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology (Baltimore, Md.). 2003-07, 38 (1): 238–243 [2021-03-01]. ISSN 0270-9139. PMID 12830007. doi:10.1053/jhep.2003.50276. （原始内容存档于2021-05-06）.
Angeli, P.; Volpin, R.; Gerunda, G.; Craighero, R.; Roner, P.; Merenda, R.; Amodio, P.; Sticca, A.; Caregaro, L. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (Baltimore, Md.). 1999-06, 29 (6): 1690–1697 [2021-03-01]. ISSN 0270-9139. PMID 10347109. doi:10.1002/hep.510290629. （原始内容存档于2021-05-06）.
Esrailian, Eric; Pantangco, Eugene R.; Kyulo, Namgyal L.; Hu, Ke-Qin; Runyon, Bruce A. Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Digestive Diseases and Sciences. 2007-03, 52 (3): 742–748 [2021-03-01]. ISSN 0163-2116. PMID 17235705. doi:10.1007/s10620-006-9312-0. （原始内容存档于2021-05-06）.
Gülberg, V.; Bilzer, M.; Gerbes, A. L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology (Baltimore, Md.). 1999-10, 30 (4): 870–875 [2021-03-01]. ISSN 0270-9139. PMID 10498636. doi:10.1002/hep.510300430. （原始内容存档于2021-05-06）.
Gluud, Lise Lotte; Christensen, Kurt; Christensen, Erik; Krag, Aleksander. Terlipressin for hepatorenal syndrome. The Cochrane Database of Systematic Reviews. 2012-09-12, (9): CD005162 [2021-03-01]. ISSN 1469-493X. PMID 22972083. doi:10.1002/14651858.CD005162.pub3. （原始内容存档于2021-05-06）.
Fernández, Javier; Navasa, Miquel; Planas, Ramón; Montoliu, Silvia; Monfort, David; Soriano, German; Vila, Carmen; Pardo, Alberto; Quintero, Enrique. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007-09, 133 (3): 818–824 [2021-03-01]. ISSN 0016-5085. PMID 17854593. doi:10.1053/j.gastro.2007.06.065. （原始内容存档于2021-05-06）.
Akriviadis, E.; Botla, R.; Briggs, W.; Han, S.; Reynolds, T.; Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000-12, 119 (6): 1637–1648 [2021-03-01]. ISSN 0016-5085. PMID 11113085. doi:10.1053/gast.2000.20189. （原始内容存档于2021-05-06）.
Holt, S.; Goodier, D.; Marley, R.; Patch, D.; Burroughs, A.; Fernando, B.; Harry, D.; Moore, K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (London, England). 1999-01-23, 353 (9149): 294–295 [2021-03-01]. ISSN 0140-6736. PMID 9929029. doi:10.1016/s0140-6736(05)74933-3. （原始内容存档于2021-05-06）.
Clewell, J. D.; Walker-Renard, P. Prostaglandins for the treatment of hepatorenal syndrome. The Annals of Pharmacotherapy. 1994-01, 28 (1): 54–55 [2021-03-01]. ISSN 1060-0280. PMID 8123962. （原始内容存档于2021-05-06）.
Wong, Florence; Pantea, Lavinia; Sniderman, Kenneth. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (Baltimore, Md.). 2004-07, 40 (1): 55–64 [2021-03-01]. ISSN 0270-9139. PMID 15239086. doi:10.1002/hep.20262. （原始内容存档于2021-05-06）.
Guevara, Mónica; Rodés, Juan. Hepatorenal syndrome. The International Journal of Biochemistry & Cell Biology. 2005-01, 37 (1): 22–26 [2021-03-01]. ISSN 1357-2725. PMID 15381144. doi:10.1016/j.biocel.2004.06.007. （原始内容存档于2021-05-06）.
Mitzner, S. R.; Stange, J.; Klammt, S.; Risler, T.; Erley, C. M.; Bader, B. D.; Berger, E. D.; Lauchart, W.; Peszynski, P. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000-05, 6 (3): 277–286 [2021-03-01]. ISSN 1527-6465. PMID 10827226. doi:10.1002/lt.500060326. （原始内容存档于2021-05-06）.
Dundar, Halit Ziya. Management of hepatorenal syndrome. World Journal of Nephrology. 2015, 4 (2): 277 [2021-03-01]. ISSN 2220-6124. PMC 4419138 . PMID 25949942. doi:10.5527/wjn.v4.i2.277. （原始内容存档于2021-05-06）（英语）.
Wong, Leslie P.; Blackley, Molly P.; Andreoni, Kenneth A.; Chin, Hyunsook; Falk, Ronald J.; Klemmer, Philip J. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney International. 2005-07, 68 (1): 362–370 [2021-03-01]. ISSN 0085-2538. PMID 15954928. doi:10.1111/j.1523-1755.2005.00408.x. （原始内容存档于2021-05-06）.
Ginès, Pere; Schrier, Robert W. Renal Failure in Cirrhosis. New England Journal of Medicine. 2009-09-24, 361 (13): 1279–1290. ISSN 0028-4793. PMID 19776409. doi:10.1056/NEJMra0809139 （英语）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Alessandria, Carlo; Ozdogan, Osman; Guevara, Mónica; Restuccia, Tea; Jiménez, Wladimiro; Arroyo, Vicente; Rodés, Juan; Ginès, Pere. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (Baltimore, Md.). 2005-06, 41 (6): 1282–1289 [2021-03-01]. ISSN 0270-9139. PMID 15834937. doi:10.1002/hep.20687. （原始内容存档于2021-05-06）.
Low, G.; Alexander, G. J. M.; Lomas, D. J. Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterology Research and Practice. 2015, 2015: 1–11 [2017-11-25]. ISSN 1687-6121. PMC 4306364 . PMID 25649410. doi:10.1155/2015/207012. （原始内容存档于2021-05-06）（英语）.
Better, O. S. Renal and cardiovascular dysfunction in liver disease. Kidney International. 1986-02, 29 (2): 598–607 [2021-03-01]. ISSN 0085-2538. PMID 3702216. doi:10.1038/ki.1986.40. （原始内容存档于2021-05-06）.
Hecker, R.; Sherlock, S. Electrolyte and circulatory changes in terminal liver failure. Lancet (London, England). 1956-12-01, 271 (6953): 1121–1125 [2021-03-01]. ISSN 0140-6736. PMID 13377688. doi:10.1016/s0140-6736(56)90149-0. （原始内容存档于2021-05-06）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Koppel, Marcelo H.; Coburn, Jack W.; Mims, Matlock M.; Goldstein, Howard; Boyle, James D.; Rubini, Milton E. Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome: Evidence for the Functional Nature of Renal Failure in Advanced Liver Disease. New England Journal of Medicine. 1969-06-19, 280 (25): 1367–1371. ISSN 0028-4793. PMID 4890476. doi:10.1056/NEJM196906192802501 （英语）.

pubmed.ncbi.nlm.nih.gov

Ng, Charles K. F.; Chan, Michael H. M.; Tai, Morris H. L.; Lam, Christopher W. K. Hepatorenal syndrome. The Clinical Biochemist. Reviews. 2007-02, 28 (1): 11–17 [2021-03-01]. ISSN 0159-8090. PMC 1904420 . PMID 17603637. （原始内容存档于2021-05-06）.
Arroyo, V.; Ginès, P.; Gerbes, A. L.; Dudley, F. J.; Gentilini, P.; Laffi, G.; Reynolds, T. B.; Ring-Larsen, H.; Schölmerich, J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (Baltimore, Md.). 1996-01, 23 (1): 164–176 [2021-03-01]. ISSN 0270-9139. PMID 8550036. doi:10.1002/hep.510230122. （原始内容存档于2021-05-06）.
Ginés, P.; Arroyo, V.; Quintero, E.; Planas, R.; Bory, F.; Cabrera, J.; Rimola, A.; Viver, J.; Camps, J. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987-08, 93 (2): 234–241 [2021-03-01]. ISSN 0016-5085. PMID 3297907. doi:10.1016/0016-5085(87)91007-9. （原始内容存档于2021-05-06）.
Blendis, Laurie; Wong, Florence. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clinical Medicine (London, England). 2003-03, 3 (2): 154–159 [2021-03-01]. ISSN 1470-2118. PMC 4952737 . PMID 12737373. doi:10.7861/clinmedicine.3-2-154. （原始内容存档于2021-05-06）.
Ginès, A.; Escorsell, A.; Ginès, P.; Saló, J.; Jiménez, W.; Inglada, L.; Navasa, M.; Clària, J.; Rimola, A. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993-07, 105 (1): 229–236 [2021-03-01]. ISSN 0016-5085. PMID 8514039. doi:10.1016/0016-5085(93)90031-7. （原始内容存档于2021-05-06）.
Han, Steven-Huy B. Extrahepatic manifestations of chronic hepatitis B. Clinics in Liver Disease. 2004-05, 8 (2): 403–418 [2021-03-01]. ISSN 1089-3261. PMID 15481347. doi:10.1016/j.cld.2004.02.003. （原始内容存档于2021-05-06）.
Philipneri, M.; Bastani, B. Kidney disease in patients with chronic hepatitis C. Current Gastroenterology Reports. 2001-02, 3 (1): 79–83 [2021-03-01]. ISSN 1522-8037. PMID 11177699. doi:10.1007/s11894-001-0045-0. （原始内容存档于2021-05-06）.
Schrier, R. W.; Arroyo, V.; Bernardi, M.; Epstein, M.; Henriksen, J. H.; Rodés, J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (Baltimore, Md.). 1988-09, 8 (5): 1151–1157 [2021-03-01]. ISSN 0270-9139. PMID 2971015. doi:10.1002/hep.1840080532. （原始内容存档于2021-05-06）.
Epstein, M. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. Journal of the American Society of Nephrology: JASN. 1994-04, 4 (10): 1735–1753 [2021-03-01]. ISSN 1046-6673. PMID 8068872. （原始内容存档于2021-05-06）.
Fernandez-Seara, J.; Prieto, J.; Quiroga, J.; Zozaya, J. M.; Cobos, M. A.; Rodriguez-Eire, J. L.; Garcia-Plaza, A.; Leal, J. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989-11, 97 (5): 1304–1312 [2021-03-01]. ISSN 0016-5085. PMID 2676683. doi:10.1016/0016-5085(89)91704-6. （原始内容存档于2021-05-06）.
Lenz, K.; Hörtnagl, H.; Druml, W.; Reither, H.; Schmid, R.; Schneeweiss, B.; Laggner, A.; Grimm, G.; Gerbes, A. L. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991-10, 101 (4): 1060–1067 [2021-03-01]. ISSN 0016-5085. PMID 1832407. doi:10.1016/0016-5085(91)90734-3. （原始内容存档于2021-05-06）.
Moore, K.; Ward, P. S.; Taylor, G. W.; Williams, R. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 1991-04, 100 (4): 1069–1077 [2021-03-01]. ISSN 0016-5085. PMID 2001805. doi:10.1016/0016-5085(91)90284-r. （原始内容存档于2021-05-06）.
Kaffy, F.; Borderie, C.; Chagneau, C.; Ripault, M. P.; Larzillière, I.; Silvain, C.; Beauchant, M. Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients. Journal of Hepatology. 1999-01, 30 (1): 174 [2021-03-01]. ISSN 0168-8278. PMID 9927168. doi:10.1016/s0168-8278(99)80025-7. （原始内容存档于2021-05-06）.
Schroeder, E. T.; Anderson, G. H.; Smulyan, H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney International. 1979-01, 15 (1): 54–61 [2021-03-01]. ISSN 0085-2538. PMID 491398. doi:10.1038/ki.1979.8. （原始内容存档于2021-05-06）.
Velamati, Praveena G.; Herlong, H. Franklin. Treatment of refractory ascites. Current Treatment Options in Gastroenterology. 2006, 9 (6): 530–537 [2021-03-01]. ISSN 1092-8472. PMID 17081486. doi:10.1007/s11938-006-0009-4. （原始内容存档于2021-05-06）.
Wong, F.; Blendis, L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology (Baltimore, Md.). 2001-12, 34 (6): 1242–1251 [2021-03-01]. ISSN 0270-9139. PMID 11732014. doi:10.1053/jhep.2001.29200. （原始内容存档于2021-05-06）.
Guevara, M.; Ginès, P.; Fernández-Esparrach, G.; Sort, P.; Salmerón, J. M.; Jiménez, W.; Arroyo, V.; Rodés, J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology (Baltimore, Md.). 1998-01, 27 (1): 35–41 [2021-03-01]. ISSN 0270-9139. PMID 9425914. doi:10.1002/hep.510270107. （原始内容存档于2021-05-06）.
Ortega, Rolando; Ginès, Pere; Uriz, Juan; Cárdenas, Andrés; Calahorra, Blas; De Las Heras, Dara; Guevara, Mónica; Bataller, Ramón; Jiménez, Wladimiro. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology (Baltimore, Md.). 2002-10, 36 (4 Pt 1): 941–948 [2021-03-01]. ISSN 0270-9139. PMID 12297842. doi:10.1053/jhep.2002.35819. （原始内容存档于2021-05-06）.
Martín-Llahí, Marta; Pépin, Marie-Noëlle; Guevara, Mónica; Díaz, Fernando; Torre, Aldo; Monescillo, Alberto; Soriano, Germán; Terra, Carlos; Fábrega, Emilio. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008-05, 134 (5): 1352–1359 [2021-03-01]. ISSN 1528-0012. PMID 18471512. doi:10.1053/j.gastro.2008.02.024. （原始内容存档于2021-05-06）.
Pomier-Layrargues, Gilles; Paquin, Sarto C.; Hassoun, Ziad; Lafortune, Michel; Tran, Albert. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology (Baltimore, Md.). 2003-07, 38 (1): 238–243 [2021-03-01]. ISSN 0270-9139. PMID 12830007. doi:10.1053/jhep.2003.50276. （原始内容存档于2021-05-06）.
Angeli, P.; Volpin, R.; Gerunda, G.; Craighero, R.; Roner, P.; Merenda, R.; Amodio, P.; Sticca, A.; Caregaro, L. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (Baltimore, Md.). 1999-06, 29 (6): 1690–1697 [2021-03-01]. ISSN 0270-9139. PMID 10347109. doi:10.1002/hep.510290629. （原始内容存档于2021-05-06）.
Esrailian, Eric; Pantangco, Eugene R.; Kyulo, Namgyal L.; Hu, Ke-Qin; Runyon, Bruce A. Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Digestive Diseases and Sciences. 2007-03, 52 (3): 742–748 [2021-03-01]. ISSN 0163-2116. PMID 17235705. doi:10.1007/s10620-006-9312-0. （原始内容存档于2021-05-06）.
Gülberg, V.; Bilzer, M.; Gerbes, A. L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology (Baltimore, Md.). 1999-10, 30 (4): 870–875 [2021-03-01]. ISSN 0270-9139. PMID 10498636. doi:10.1002/hep.510300430. （原始内容存档于2021-05-06）.
Gluud, Lise Lotte; Christensen, Kurt; Christensen, Erik; Krag, Aleksander. Terlipressin for hepatorenal syndrome. The Cochrane Database of Systematic Reviews. 2012-09-12, (9): CD005162 [2021-03-01]. ISSN 1469-493X. PMID 22972083. doi:10.1002/14651858.CD005162.pub3. （原始内容存档于2021-05-06）.
Fernández, Javier; Navasa, Miquel; Planas, Ramón; Montoliu, Silvia; Monfort, David; Soriano, German; Vila, Carmen; Pardo, Alberto; Quintero, Enrique. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007-09, 133 (3): 818–824 [2021-03-01]. ISSN 0016-5085. PMID 17854593. doi:10.1053/j.gastro.2007.06.065. （原始内容存档于2021-05-06）.
Akriviadis, E.; Botla, R.; Briggs, W.; Han, S.; Reynolds, T.; Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000-12, 119 (6): 1637–1648 [2021-03-01]. ISSN 0016-5085. PMID 11113085. doi:10.1053/gast.2000.20189. （原始内容存档于2021-05-06）.
Holt, S.; Goodier, D.; Marley, R.; Patch, D.; Burroughs, A.; Fernando, B.; Harry, D.; Moore, K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (London, England). 1999-01-23, 353 (9149): 294–295 [2021-03-01]. ISSN 0140-6736. PMID 9929029. doi:10.1016/s0140-6736(05)74933-3. （原始内容存档于2021-05-06）.
Clewell, J. D.; Walker-Renard, P. Prostaglandins for the treatment of hepatorenal syndrome. The Annals of Pharmacotherapy. 1994-01, 28 (1): 54–55 [2021-03-01]. ISSN 1060-0280. PMID 8123962. （原始内容存档于2021-05-06）.
Wong, Florence; Pantea, Lavinia; Sniderman, Kenneth. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (Baltimore, Md.). 2004-07, 40 (1): 55–64 [2021-03-01]. ISSN 0270-9139. PMID 15239086. doi:10.1002/hep.20262. （原始内容存档于2021-05-06）.
Guevara, Mónica; Rodés, Juan. Hepatorenal syndrome. The International Journal of Biochemistry & Cell Biology. 2005-01, 37 (1): 22–26 [2021-03-01]. ISSN 1357-2725. PMID 15381144. doi:10.1016/j.biocel.2004.06.007. （原始内容存档于2021-05-06）.
Mitzner, S. R.; Stange, J.; Klammt, S.; Risler, T.; Erley, C. M.; Bader, B. D.; Berger, E. D.; Lauchart, W.; Peszynski, P. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000-05, 6 (3): 277–286 [2021-03-01]. ISSN 1527-6465. PMID 10827226. doi:10.1002/lt.500060326. （原始内容存档于2021-05-06）.
Wong, Leslie P.; Blackley, Molly P.; Andreoni, Kenneth A.; Chin, Hyunsook; Falk, Ronald J.; Klemmer, Philip J. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney International. 2005-07, 68 (1): 362–370 [2021-03-01]. ISSN 0085-2538. PMID 15954928. doi:10.1111/j.1523-1755.2005.00408.x. （原始内容存档于2021-05-06）.
Alessandria, Carlo; Ozdogan, Osman; Guevara, Mónica; Restuccia, Tea; Jiménez, Wladimiro; Arroyo, Vicente; Rodés, Juan; Ginès, Pere. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (Baltimore, Md.). 2005-06, 41 (6): 1282–1289 [2021-03-01]. ISSN 0270-9139. PMID 15834937. doi:10.1002/hep.20687. （原始内容存档于2021-05-06）.
Better, O. S. Renal and cardiovascular dysfunction in liver disease. Kidney International. 1986-02, 29 (2): 598–607 [2021-03-01]. ISSN 0085-2538. PMID 3702216. doi:10.1038/ki.1986.40. （原始内容存档于2021-05-06）.
Hecker, R.; Sherlock, S. Electrolyte and circulatory changes in terminal liver failure. Lancet (London, England). 1956-12-01, 271 (6953): 1121–1125 [2021-03-01]. ISSN 0140-6736. PMID 13377688. doi:10.1016/s0140-6736(56)90149-0. （原始内容存档于2021-05-06）.

uptodate.com (Global: 3,771^st place; Chinese: 4,225^th place)

Hepatorenal syndrome. www.uptodate.com. [2017-11-25]. （原始内容存档于2020-02-27）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Ng, Charles K. F.; Chan, Michael H. M.; Tai, Morris H. L.; Lam, Christopher W. K. Hepatorenal syndrome. The Clinical Biochemist. Reviews. 2007-02, 28 (1): 11–17 [2021-03-01]. ISSN 0159-8090. PMC 1904420 . PMID 17603637. （原始内容存档于2021-05-06）.
Ginès, Pere; Arroyo, Vicente. Hepatorenal Syndrome. Journal of the American Society of Nephrology. 1999-08-01, 10 (8): 1833–1839 [2021-03-01]. ISSN 1046-6673. PMID 10446954. （原始内容存档于2021-05-06）（英语）.
Arroyo, V.; Ginès, P.; Gerbes, A. L.; Dudley, F. J.; Gentilini, P.; Laffi, G.; Reynolds, T. B.; Ring-Larsen, H.; Schölmerich, J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (Baltimore, Md.). 1996-01, 23 (1): 164–176 [2021-03-01]. ISSN 0270-9139. PMID 8550036. doi:10.1002/hep.510230122. （原始内容存档于2021-05-06）.
Arroyo, Vicente; Guevara, Mónica; Ginès, Pere. Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment. Gastroenterology. 2002-05, 122 (6): 1658–1676 [2020-09-17]. PMID 12016430. doi:10.1053/gast.2002.33575. （原始内容存档于2019-06-06）（英语）.
Hepatorenal Syndrome: Background, Pathophysiology, Etiology. 2020-03-23 [2021-03-01]. （原始内容存档于2017-08-10）.
Lenz, Kurt; Buder, Robert; Kapun, Lisbeth; Voglmayr, Martin. Treatment and management of ascites and hepatorenal syndrome: an update. Therapeutic Advances in Gastroenterology. 2015-03, 8 (2): 83–100 [2019-01-09]. ISSN 1756-283X. PMC 4314304 . PMID 25729433. doi:10.1177/1756283X14564673. （原始内容存档于2021-05-06）.
Ginés, P.; Arroyo, V.; Quintero, E.; Planas, R.; Bory, F.; Cabrera, J.; Rimola, A.; Viver, J.; Camps, J. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987-08, 93 (2): 234–241 [2021-03-01]. ISSN 0016-5085. PMID 3297907. doi:10.1016/0016-5085(87)91007-9. （原始内容存档于2021-05-06）.
Blendis, Laurie; Wong, Florence. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clinical Medicine (London, England). 2003-03, 3 (2): 154–159 [2021-03-01]. ISSN 1470-2118. PMC 4952737 . PMID 12737373. doi:10.7861/clinmedicine.3-2-154. （原始内容存档于2021-05-06）.
Ginès, A.; Escorsell, A.; Ginès, P.; Saló, J.; Jiménez, W.; Inglada, L.; Navasa, M.; Clària, J.; Rimola, A. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993-07, 105 (1): 229–236 [2021-03-01]. ISSN 0016-5085. PMID 8514039. doi:10.1016/0016-5085(93)90031-7. （原始内容存档于2021-05-06）.
Han, Steven-Huy B. Extrahepatic manifestations of chronic hepatitis B. Clinics in Liver Disease. 2004-05, 8 (2): 403–418 [2021-03-01]. ISSN 1089-3261. PMID 15481347. doi:10.1016/j.cld.2004.02.003. （原始内容存档于2021-05-06）.
Philipneri, M.; Bastani, B. Kidney disease in patients with chronic hepatitis C. Current Gastroenterology Reports. 2001-02, 3 (1): 79–83 [2021-03-01]. ISSN 1522-8037. PMID 11177699. doi:10.1007/s11894-001-0045-0. （原始内容存档于2021-05-06）.
Schrier, R. W.; Arroyo, V.; Bernardi, M.; Epstein, M.; Henriksen, J. H.; Rodés, J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (Baltimore, Md.). 1988-09, 8 (5): 1151–1157 [2021-03-01]. ISSN 0270-9139. PMID 2971015. doi:10.1002/hep.1840080532. （原始内容存档于2021-05-06）.
Martin, Pierre-Yves; Ginès, Pere; Schrier, Robert W. Epstein, Franklin H. , 编. Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis. New England Journal of Medicine. 1998-08-20, 339 (8): 533–541 [2021-03-01]. ISSN 0028-4793. PMID 9709047. doi:10.1056/NEJM199808203390807. （原始内容存档于2021-05-06）（英语）.
Epstein, M. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. Journal of the American Society of Nephrology: JASN. 1994-04, 4 (10): 1735–1753 [2021-03-01]. ISSN 1046-6673. PMID 8068872. （原始内容存档于2021-05-06）.
Fernandez-Seara, J.; Prieto, J.; Quiroga, J.; Zozaya, J. M.; Cobos, M. A.; Rodriguez-Eire, J. L.; Garcia-Plaza, A.; Leal, J. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989-11, 97 (5): 1304–1312 [2021-03-01]. ISSN 0016-5085. PMID 2676683. doi:10.1016/0016-5085(89)91704-6. （原始内容存档于2021-05-06）.
Lenz, K.; Hörtnagl, H.; Druml, W.; Reither, H.; Schmid, R.; Schneeweiss, B.; Laggner, A.; Grimm, G.; Gerbes, A. L. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991-10, 101 (4): 1060–1067 [2021-03-01]. ISSN 0016-5085. PMID 1832407. doi:10.1016/0016-5085(91)90734-3. （原始内容存档于2021-05-06）.
Moore, K.; Ward, P. S.; Taylor, G. W.; Williams, R. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 1991-04, 100 (4): 1069–1077 [2021-03-01]. ISSN 0016-5085. PMID 2001805. doi:10.1016/0016-5085(91)90284-r. （原始内容存档于2021-05-06）.
Kaffy, F.; Borderie, C.; Chagneau, C.; Ripault, M. P.; Larzillière, I.; Silvain, C.; Beauchant, M. Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients. Journal of Hepatology. 1999-01, 30 (1): 174 [2021-03-01]. ISSN 0168-8278. PMID 9927168. doi:10.1016/s0168-8278(99)80025-7. （原始内容存档于2021-05-06）.
Schroeder, E. T.; Anderson, G. H.; Smulyan, H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney International. 1979-01, 15 (1): 54–61 [2021-03-01]. ISSN 0085-2538. PMID 491398. doi:10.1038/ki.1979.8. （原始内容存档于2021-05-06）.
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology. 2010-09, 53 (3): 397–417 [2021-03-01]. doi:10.1016/j.jhep.2010.05.004. （原始内容存档于2021-05-06）（英语）.
Velamati, Praveena G.; Herlong, H. Franklin. Treatment of refractory ascites. Current Treatment Options in Gastroenterology. 2006, 9 (6): 530–537 [2021-03-01]. ISSN 1092-8472. PMID 17081486. doi:10.1007/s11938-006-0009-4. （原始内容存档于2021-05-06）.
Wong, F.; Blendis, L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology (Baltimore, Md.). 2001-12, 34 (6): 1242–1251 [2021-03-01]. ISSN 0270-9139. PMID 11732014. doi:10.1053/jhep.2001.29200. （原始内容存档于2021-05-06）.
Guevara, M.; Ginès, P.; Fernández-Esparrach, G.; Sort, P.; Salmerón, J. M.; Jiménez, W.; Arroyo, V.; Rodés, J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology (Baltimore, Md.). 1998-01, 27 (1): 35–41 [2021-03-01]. ISSN 0270-9139. PMID 9425914. doi:10.1002/hep.510270107. （原始内容存档于2021-05-06）.
Ortega, Rolando; Ginès, Pere; Uriz, Juan; Cárdenas, Andrés; Calahorra, Blas; De Las Heras, Dara; Guevara, Mónica; Bataller, Ramón; Jiménez, Wladimiro. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology (Baltimore, Md.). 2002-10, 36 (4 Pt 1): 941–948 [2021-03-01]. ISSN 0270-9139. PMID 12297842. doi:10.1053/jhep.2002.35819. （原始内容存档于2021-05-06）.
Martín-Llahí, Marta; Pépin, Marie-Noëlle; Guevara, Mónica; Díaz, Fernando; Torre, Aldo; Monescillo, Alberto; Soriano, Germán; Terra, Carlos; Fábrega, Emilio. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008-05, 134 (5): 1352–1359 [2021-03-01]. ISSN 1528-0012. PMID 18471512. doi:10.1053/j.gastro.2008.02.024. （原始内容存档于2021-05-06）.
Pomier-Layrargues, Gilles; Paquin, Sarto C.; Hassoun, Ziad; Lafortune, Michel; Tran, Albert. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology (Baltimore, Md.). 2003-07, 38 (1): 238–243 [2021-03-01]. ISSN 0270-9139. PMID 12830007. doi:10.1053/jhep.2003.50276. （原始内容存档于2021-05-06）.
Angeli, P.; Volpin, R.; Gerunda, G.; Craighero, R.; Roner, P.; Merenda, R.; Amodio, P.; Sticca, A.; Caregaro, L. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (Baltimore, Md.). 1999-06, 29 (6): 1690–1697 [2021-03-01]. ISSN 0270-9139. PMID 10347109. doi:10.1002/hep.510290629. （原始内容存档于2021-05-06）.
Esrailian, Eric; Pantangco, Eugene R.; Kyulo, Namgyal L.; Hu, Ke-Qin; Runyon, Bruce A. Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Digestive Diseases and Sciences. 2007-03, 52 (3): 742–748 [2021-03-01]. ISSN 0163-2116. PMID 17235705. doi:10.1007/s10620-006-9312-0. （原始内容存档于2021-05-06）.
Gülberg, V.; Bilzer, M.; Gerbes, A. L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology (Baltimore, Md.). 1999-10, 30 (4): 870–875 [2021-03-01]. ISSN 0270-9139. PMID 10498636. doi:10.1002/hep.510300430. （原始内容存档于2021-05-06）.
Gluud, Lise Lotte; Christensen, Kurt; Christensen, Erik; Krag, Aleksander. Terlipressin for hepatorenal syndrome. The Cochrane Database of Systematic Reviews. 2012-09-12, (9): CD005162 [2021-03-01]. ISSN 1469-493X. PMID 22972083. doi:10.1002/14651858.CD005162.pub3. （原始内容存档于2021-05-06）.
Fernández, Javier; Navasa, Miquel; Planas, Ramón; Montoliu, Silvia; Monfort, David; Soriano, German; Vila, Carmen; Pardo, Alberto; Quintero, Enrique. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007-09, 133 (3): 818–824 [2021-03-01]. ISSN 0016-5085. PMID 17854593. doi:10.1053/j.gastro.2007.06.065. （原始内容存档于2021-05-06）.
Akriviadis, E.; Botla, R.; Briggs, W.; Han, S.; Reynolds, T.; Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000-12, 119 (6): 1637–1648 [2021-03-01]. ISSN 0016-5085. PMID 11113085. doi:10.1053/gast.2000.20189. （原始内容存档于2021-05-06）.
Holt, S.; Goodier, D.; Marley, R.; Patch, D.; Burroughs, A.; Fernando, B.; Harry, D.; Moore, K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (London, England). 1999-01-23, 353 (9149): 294–295 [2021-03-01]. ISSN 0140-6736. PMID 9929029. doi:10.1016/s0140-6736(05)74933-3. （原始内容存档于2021-05-06）.
Clewell, J. D.; Walker-Renard, P. Prostaglandins for the treatment of hepatorenal syndrome. The Annals of Pharmacotherapy. 1994-01, 28 (1): 54–55 [2021-03-01]. ISSN 1060-0280. PMID 8123962. （原始内容存档于2021-05-06）.
Wong, Florence; Pantea, Lavinia; Sniderman, Kenneth. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (Baltimore, Md.). 2004-07, 40 (1): 55–64 [2021-03-01]. ISSN 0270-9139. PMID 15239086. doi:10.1002/hep.20262. （原始内容存档于2021-05-06）.
Guevara, Mónica; Rodés, Juan. Hepatorenal syndrome. The International Journal of Biochemistry & Cell Biology. 2005-01, 37 (1): 22–26 [2021-03-01]. ISSN 1357-2725. PMID 15381144. doi:10.1016/j.biocel.2004.06.007. （原始内容存档于2021-05-06）.
Mitzner, S. R.; Stange, J.; Klammt, S.; Risler, T.; Erley, C. M.; Bader, B. D.; Berger, E. D.; Lauchart, W.; Peszynski, P. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000-05, 6 (3): 277–286 [2021-03-01]. ISSN 1527-6465. PMID 10827226. doi:10.1002/lt.500060326. （原始内容存档于2021-05-06）.
Dundar, Halit Ziya. Management of hepatorenal syndrome. World Journal of Nephrology. 2015, 4 (2): 277 [2021-03-01]. ISSN 2220-6124. PMC 4419138 . PMID 25949942. doi:10.5527/wjn.v4.i2.277. （原始内容存档于2021-05-06）（英语）.
Wong, Leslie P.; Blackley, Molly P.; Andreoni, Kenneth A.; Chin, Hyunsook; Falk, Ronald J.; Klemmer, Philip J. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney International. 2005-07, 68 (1): 362–370 [2021-03-01]. ISSN 0085-2538. PMID 15954928. doi:10.1111/j.1523-1755.2005.00408.x. （原始内容存档于2021-05-06）.
Hepatorenal syndrome. www.uptodate.com. [2017-11-25]. （原始内容存档于2020-02-27）.
Alessandria, Carlo; Ozdogan, Osman; Guevara, Mónica; Restuccia, Tea; Jiménez, Wladimiro; Arroyo, Vicente; Rodés, Juan; Ginès, Pere. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (Baltimore, Md.). 2005-06, 41 (6): 1282–1289 [2021-03-01]. ISSN 0270-9139. PMID 15834937. doi:10.1002/hep.20687. （原始内容存档于2021-05-06）.
Low, G.; Alexander, G. J. M.; Lomas, D. J. Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterology Research and Practice. 2015, 2015: 1–11 [2017-11-25]. ISSN 1687-6121. PMC 4306364 . PMID 25649410. doi:10.1155/2015/207012. （原始内容存档于2021-05-06）（英语）.
Better, O. S. Renal and cardiovascular dysfunction in liver disease. Kidney International. 1986-02, 29 (2): 598–607 [2021-03-01]. ISSN 0085-2538. PMID 3702216. doi:10.1038/ki.1986.40. （原始内容存档于2021-05-06）.
Helwig, F. C.; Schutz, C. B. A liver kidney syndrome. Clinical, pathological and experimental studies.. Surg Gynaecol Obstet. 1932, 55: 570–580 [2021-03-01]. （原始内容存档于2021-05-06）（英国英语）.
Hecker, R.; Sherlock, S. Electrolyte and circulatory changes in terminal liver failure. Lancet (London, England). 1956-12-01, 271 (6953): 1121–1125 [2021-03-01]. ISSN 0140-6736. PMID 13377688. doi:10.1016/s0140-6736(56)90149-0. （原始内容存档于2021-05-06）.

wjgnet.com (Global: low place; Chinese: 6,583^rd place)

Dundar, Halit Ziya. Management of hepatorenal syndrome. World Journal of Nephrology. 2015, 4 (2): 277 [2021-03-01]. ISSN 2220-6124. PMC 4419138 . PMID 25949942. doi:10.5527/wjn.v4.i2.277. （原始内容存档于2021-05-06）（英语）.

worldcat.org (Global: 5^th place; Chinese: 12^th place)

Ng, Charles K. F.; Chan, Michael H. M.; Tai, Morris H. L.; Lam, Christopher W. K. Hepatorenal syndrome. The Clinical Biochemist. Reviews. 2007-02, 28 (1): 11–17 [2021-03-01]. ISSN 0159-8090. PMC 1904420 . PMID 17603637. （原始内容存档于2021-05-06）.
Ginès, Pere; Arroyo, Vicente. Hepatorenal Syndrome. Journal of the American Society of Nephrology. 1999-08-01, 10 (8): 1833–1839 [2021-03-01]. ISSN 1046-6673. PMID 10446954. （原始内容存档于2021-05-06）（英语）.
Arroyo, V.; Ginès, P.; Gerbes, A. L.; Dudley, F. J.; Gentilini, P.; Laffi, G.; Reynolds, T. B.; Ring-Larsen, H.; Schölmerich, J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (Baltimore, Md.). 1996-01, 23 (1): 164–176 [2021-03-01]. ISSN 0270-9139. PMID 8550036. doi:10.1002/hep.510230122. （原始内容存档于2021-05-06）.
Lenz, Kurt; Buder, Robert; Kapun, Lisbeth; Voglmayr, Martin. Treatment and management of ascites and hepatorenal syndrome: an update. Therapeutic Advances in Gastroenterology. 2015-03, 8 (2): 83–100 [2019-01-09]. ISSN 1756-283X. PMC 4314304 . PMID 25729433. doi:10.1177/1756283X14564673. （原始内容存档于2021-05-06）.
Ginés, P.; Arroyo, V.; Quintero, E.; Planas, R.; Bory, F.; Cabrera, J.; Rimola, A.; Viver, J.; Camps, J. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987-08, 93 (2): 234–241 [2021-03-01]. ISSN 0016-5085. PMID 3297907. doi:10.1016/0016-5085(87)91007-9. （原始内容存档于2021-05-06）.
Blendis, Laurie; Wong, Florence. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clinical Medicine (London, England). 2003-03, 3 (2): 154–159 [2021-03-01]. ISSN 1470-2118. PMC 4952737 . PMID 12737373. doi:10.7861/clinmedicine.3-2-154. （原始内容存档于2021-05-06）.
Ginès, A.; Escorsell, A.; Ginès, P.; Saló, J.; Jiménez, W.; Inglada, L.; Navasa, M.; Clària, J.; Rimola, A. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993-07, 105 (1): 229–236 [2021-03-01]. ISSN 0016-5085. PMID 8514039. doi:10.1016/0016-5085(93)90031-7. （原始内容存档于2021-05-06）.
Han, Steven-Huy B. Extrahepatic manifestations of chronic hepatitis B. Clinics in Liver Disease. 2004-05, 8 (2): 403–418 [2021-03-01]. ISSN 1089-3261. PMID 15481347. doi:10.1016/j.cld.2004.02.003. （原始内容存档于2021-05-06）.
Philipneri, M.; Bastani, B. Kidney disease in patients with chronic hepatitis C. Current Gastroenterology Reports. 2001-02, 3 (1): 79–83 [2021-03-01]. ISSN 1522-8037. PMID 11177699. doi:10.1007/s11894-001-0045-0. （原始内容存档于2021-05-06）.
Schrier, R. W.; Arroyo, V.; Bernardi, M.; Epstein, M.; Henriksen, J. H.; Rodés, J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (Baltimore, Md.). 1988-09, 8 (5): 1151–1157 [2021-03-01]. ISSN 0270-9139. PMID 2971015. doi:10.1002/hep.1840080532. （原始内容存档于2021-05-06）.
Martin, Pierre-Yves; Ginès, Pere; Schrier, Robert W. Epstein, Franklin H. , 编. Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis. New England Journal of Medicine. 1998-08-20, 339 (8): 533–541 [2021-03-01]. ISSN 0028-4793. PMID 9709047. doi:10.1056/NEJM199808203390807. （原始内容存档于2021-05-06）（英语）.
Epstein, M. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. Journal of the American Society of Nephrology: JASN. 1994-04, 4 (10): 1735–1753 [2021-03-01]. ISSN 1046-6673. PMID 8068872. （原始内容存档于2021-05-06）.
Fernandez-Seara, J.; Prieto, J.; Quiroga, J.; Zozaya, J. M.; Cobos, M. A.; Rodriguez-Eire, J. L.; Garcia-Plaza, A.; Leal, J. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989-11, 97 (5): 1304–1312 [2021-03-01]. ISSN 0016-5085. PMID 2676683. doi:10.1016/0016-5085(89)91704-6. （原始内容存档于2021-05-06）.
Lenz, K.; Hörtnagl, H.; Druml, W.; Reither, H.; Schmid, R.; Schneeweiss, B.; Laggner, A.; Grimm, G.; Gerbes, A. L. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991-10, 101 (4): 1060–1067 [2021-03-01]. ISSN 0016-5085. PMID 1832407. doi:10.1016/0016-5085(91)90734-3. （原始内容存档于2021-05-06）.
Moore, K.; Ward, P. S.; Taylor, G. W.; Williams, R. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 1991-04, 100 (4): 1069–1077 [2021-03-01]. ISSN 0016-5085. PMID 2001805. doi:10.1016/0016-5085(91)90284-r. （原始内容存档于2021-05-06）.
Kaffy, F.; Borderie, C.; Chagneau, C.; Ripault, M. P.; Larzillière, I.; Silvain, C.; Beauchant, M. Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients. Journal of Hepatology. 1999-01, 30 (1): 174 [2021-03-01]. ISSN 0168-8278. PMID 9927168. doi:10.1016/s0168-8278(99)80025-7. （原始内容存档于2021-05-06）.
Schroeder, E. T.; Anderson, G. H.; Smulyan, H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney International. 1979-01, 15 (1): 54–61 [2021-03-01]. ISSN 0085-2538. PMID 491398. doi:10.1038/ki.1979.8. （原始内容存档于2021-05-06）.
Velamati, Praveena G.; Herlong, H. Franklin. Treatment of refractory ascites. Current Treatment Options in Gastroenterology. 2006, 9 (6): 530–537 [2021-03-01]. ISSN 1092-8472. PMID 17081486. doi:10.1007/s11938-006-0009-4. （原始内容存档于2021-05-06）.
Sort, Pau; Navasa, Miquel; Arroyo, Vicente; Aldeguer, Xavier; Planas, Ramon; Ruiz-del-Arbol, Luis; Castells, Lluis; Vargas, Victor; Soriano, Germán. Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. New England Journal of Medicine. 1999-08-05, 341 (6): 403–409. ISSN 0028-4793. PMID 10432325. doi:10.1056/NEJM199908053410603 （英语）.
Wong, F.; Blendis, L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology (Baltimore, Md.). 2001-12, 34 (6): 1242–1251 [2021-03-01]. ISSN 0270-9139. PMID 11732014. doi:10.1053/jhep.2001.29200. （原始内容存档于2021-05-06）.
Xu, Xiao; Ling, Qi; Zhang, Min; Gao, Feng; He, Zenglei; You, Jingya; Zheng, Shusen. Outcome of Patients With Hepatorenal Syndrome Type 1 After Liver Transplantation: Hangzhou Experience. Transplantation. 2009-05-27, 87 (10): 1514–1519. ISSN 0041-1337. PMID 19461488. doi:10.1097/TP.0b013e3181a4430b （英语）.
Guevara, M.; Ginès, P.; Fernández-Esparrach, G.; Sort, P.; Salmerón, J. M.; Jiménez, W.; Arroyo, V.; Rodés, J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology (Baltimore, Md.). 1998-01, 27 (1): 35–41 [2021-03-01]. ISSN 0270-9139. PMID 9425914. doi:10.1002/hep.510270107. （原始内容存档于2021-05-06）.
Ortega, Rolando; Ginès, Pere; Uriz, Juan; Cárdenas, Andrés; Calahorra, Blas; De Las Heras, Dara; Guevara, Mónica; Bataller, Ramón; Jiménez, Wladimiro. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology (Baltimore, Md.). 2002-10, 36 (4 Pt 1): 941–948 [2021-03-01]. ISSN 0270-9139. PMID 12297842. doi:10.1053/jhep.2002.35819. （原始内容存档于2021-05-06）.
Ginès, Pere; Cárdenas, Andrés; Arroyo, Vicente; Rodés, Juan. Management of Cirrhosis and Ascites. New England Journal of Medicine. 2004-04-15, 350 (16): 1646–1654. ISSN 0028-4793. PMID 15084697. doi:10.1056/NEJMra035021 （英语）.
Martín-Llahí, Marta; Pépin, Marie-Noëlle; Guevara, Mónica; Díaz, Fernando; Torre, Aldo; Monescillo, Alberto; Soriano, Germán; Terra, Carlos; Fábrega, Emilio. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008-05, 134 (5): 1352–1359 [2021-03-01]. ISSN 1528-0012. PMID 18471512. doi:10.1053/j.gastro.2008.02.024. （原始内容存档于2021-05-06）.
Pomier-Layrargues, Gilles; Paquin, Sarto C.; Hassoun, Ziad; Lafortune, Michel; Tran, Albert. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology (Baltimore, Md.). 2003-07, 38 (1): 238–243 [2021-03-01]. ISSN 0270-9139. PMID 12830007. doi:10.1053/jhep.2003.50276. （原始内容存档于2021-05-06）.
Angeli, P.; Volpin, R.; Gerunda, G.; Craighero, R.; Roner, P.; Merenda, R.; Amodio, P.; Sticca, A.; Caregaro, L. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (Baltimore, Md.). 1999-06, 29 (6): 1690–1697 [2021-03-01]. ISSN 0270-9139. PMID 10347109. doi:10.1002/hep.510290629. （原始内容存档于2021-05-06）.
Esrailian, Eric; Pantangco, Eugene R.; Kyulo, Namgyal L.; Hu, Ke-Qin; Runyon, Bruce A. Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Digestive Diseases and Sciences. 2007-03, 52 (3): 742–748 [2021-03-01]. ISSN 0163-2116. PMID 17235705. doi:10.1007/s10620-006-9312-0. （原始内容存档于2021-05-06）.
Gülberg, V.; Bilzer, M.; Gerbes, A. L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology (Baltimore, Md.). 1999-10, 30 (4): 870–875 [2021-03-01]. ISSN 0270-9139. PMID 10498636. doi:10.1002/hep.510300430. （原始内容存档于2021-05-06）.
Gluud, Lise Lotte; Christensen, Kurt; Christensen, Erik; Krag, Aleksander. Terlipressin for hepatorenal syndrome. The Cochrane Database of Systematic Reviews. 2012-09-12, (9): CD005162 [2021-03-01]. ISSN 1469-493X. PMID 22972083. doi:10.1002/14651858.CD005162.pub3. （原始内容存档于2021-05-06）.
Fernández, Javier; Navasa, Miquel; Planas, Ramón; Montoliu, Silvia; Monfort, David; Soriano, German; Vila, Carmen; Pardo, Alberto; Quintero, Enrique. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007-09, 133 (3): 818–824 [2021-03-01]. ISSN 0016-5085. PMID 17854593. doi:10.1053/j.gastro.2007.06.065. （原始内容存档于2021-05-06）.
Akriviadis, E.; Botla, R.; Briggs, W.; Han, S.; Reynolds, T.; Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000-12, 119 (6): 1637–1648 [2021-03-01]. ISSN 0016-5085. PMID 11113085. doi:10.1053/gast.2000.20189. （原始内容存档于2021-05-06）.
Holt, S.; Goodier, D.; Marley, R.; Patch, D.; Burroughs, A.; Fernando, B.; Harry, D.; Moore, K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (London, England). 1999-01-23, 353 (9149): 294–295 [2021-03-01]. ISSN 0140-6736. PMID 9929029. doi:10.1016/s0140-6736(05)74933-3. （原始内容存档于2021-05-06）.
Clewell, J. D.; Walker-Renard, P. Prostaglandins for the treatment of hepatorenal syndrome. The Annals of Pharmacotherapy. 1994-01, 28 (1): 54–55 [2021-03-01]. ISSN 1060-0280. PMID 8123962. （原始内容存档于2021-05-06）.
Wong, Florence; Pantea, Lavinia; Sniderman, Kenneth. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (Baltimore, Md.). 2004-07, 40 (1): 55–64 [2021-03-01]. ISSN 0270-9139. PMID 15239086. doi:10.1002/hep.20262. （原始内容存档于2021-05-06）.
Guevara, Mónica; Rodés, Juan. Hepatorenal syndrome. The International Journal of Biochemistry & Cell Biology. 2005-01, 37 (1): 22–26 [2021-03-01]. ISSN 1357-2725. PMID 15381144. doi:10.1016/j.biocel.2004.06.007. （原始内容存档于2021-05-06）.
Mitzner, S. R.; Stange, J.; Klammt, S.; Risler, T.; Erley, C. M.; Bader, B. D.; Berger, E. D.; Lauchart, W.; Peszynski, P. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000-05, 6 (3): 277–286 [2021-03-01]. ISSN 1527-6465. PMID 10827226. doi:10.1002/lt.500060326. （原始内容存档于2021-05-06）.
Dundar, Halit Ziya. Management of hepatorenal syndrome. World Journal of Nephrology. 2015, 4 (2): 277 [2021-03-01]. ISSN 2220-6124. PMC 4419138 . PMID 25949942. doi:10.5527/wjn.v4.i2.277. （原始内容存档于2021-05-06）（英语）.
Wong, Leslie P.; Blackley, Molly P.; Andreoni, Kenneth A.; Chin, Hyunsook; Falk, Ronald J.; Klemmer, Philip J. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney International. 2005-07, 68 (1): 362–370 [2021-03-01]. ISSN 0085-2538. PMID 15954928. doi:10.1111/j.1523-1755.2005.00408.x. （原始内容存档于2021-05-06）.
Ginès, Pere; Schrier, Robert W. Renal Failure in Cirrhosis. New England Journal of Medicine. 2009-09-24, 361 (13): 1279–1290. ISSN 0028-4793. PMID 19776409. doi:10.1056/NEJMra0809139 （英语）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Alessandria, Carlo; Ozdogan, Osman; Guevara, Mónica; Restuccia, Tea; Jiménez, Wladimiro; Arroyo, Vicente; Rodés, Juan; Ginès, Pere. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (Baltimore, Md.). 2005-06, 41 (6): 1282–1289 [2021-03-01]. ISSN 0270-9139. PMID 15834937. doi:10.1002/hep.20687. （原始内容存档于2021-05-06）.
Low, G.; Alexander, G. J. M.; Lomas, D. J. Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterology Research and Practice. 2015, 2015: 1–11 [2017-11-25]. ISSN 1687-6121. PMC 4306364 . PMID 25649410. doi:10.1155/2015/207012. （原始内容存档于2021-05-06）（英语）.
Better, O. S. Renal and cardiovascular dysfunction in liver disease. Kidney International. 1986-02, 29 (2): 598–607 [2021-03-01]. ISSN 0085-2538. PMID 3702216. doi:10.1038/ki.1986.40. （原始内容存档于2021-05-06）.
Hecker, R.; Sherlock, S. Electrolyte and circulatory changes in terminal liver failure. Lancet (London, England). 1956-12-01, 271 (6953): 1121–1125 [2021-03-01]. ISSN 0140-6736. PMID 13377688. doi:10.1016/s0140-6736(56)90149-0. （原始内容存档于2021-05-06）.
Wadei, Hani M.; Mai, Martin L.; Ahsan, Nasimul; Gonwa, Thomas A. Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology. 2006-09, 1 (5): 1066–1079. ISSN 1555-9041. PMID 17699328. doi:10.2215/CJN.01340406 （英语）.
Koppel, Marcelo H.; Coburn, Jack W.; Mims, Matlock M.; Goldstein, Howard; Boyle, James D.; Rubini, Milton E. Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome: Evidence for the Functional Nature of Renal Failure in Advanced Liver Disease. New England Journal of Medicine. 1969-06-19, 280 (25): 1367–1371. ISSN 0028-4793. PMID 4890476. doi:10.1056/NEJM196906192802501 （英语）.

肝肾综合征 (Chinese Wikipedia)

asnjournals.org (Global: low place; Chinese: low place)

cjasn.asnjournals.org

jasn.asnjournals.org

doi.org (Global: 2nd place; Chinese: 23rd place)

elsevier.com (Global: 610th place; Chinese: 388th place)

linkinghub.elsevier.com

hindawi.com (Global: 6,828th place; Chinese: 3,089th place)

lww.com (Global: 2,769th place; Chinese: 1,362nd place)

journals.lww.com

medscape.com (Global: 719th place; Chinese: 889th place)

emedicine.medscape.com

mendeley.com (Global: low place; Chinese: low place)

nejm.org (Global: 2,374th place; Chinese: 1,457th place)

nih.gov (Global: 4th place; Chinese: 5th place)

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

uptodate.com (Global: 3,771st place; Chinese: 4,225th place)

web.archive.org (Global: 1st place; Chinese: 1st place)

wjgnet.com (Global: low place; Chinese: 6,583rd place)

worldcat.org (Global: 5th place; Chinese: 12th place)

doi.org (Global: 2^nd place; Chinese: 23^rd place)

elsevier.com (Global: 610^th place; Chinese: 388^th place)

hindawi.com (Global: 6,828^th place; Chinese: 3,089^th place)

lww.com (Global: 2,769^th place; Chinese: 1,362^nd place)

medscape.com (Global: 719^th place; Chinese: 889^th place)

nejm.org (Global: 2,374^th place; Chinese: 1,457^th place)

nih.gov (Global: 4^th place; Chinese: 5^th place)

uptodate.com (Global: 3,771^st place; Chinese: 4,225^th place)

web.archive.org (Global: 1^st place; Chinese: 1^st place)

wjgnet.com (Global: low place; Chinese: 6,583^rd place)

worldcat.org (Global: 5^th place; Chinese: 12^th place)